Medicines Discovery Catapult (MDC) is a national facility in the UK designed to reshape drug discovery by fostering collaboration between industry, academia, and technology innovators. Providing access to specialized laboratory capabilities, advanced imaging, data analytics, and translation management, MDC helps life science innovators validate therapeutic concepts and de-risk early pipelines.
Subscribe to our newsletter
Subscribe to receive the latest news and innovations straight to your inbox.
Your subscription could not be saved. Please try again.
Bringing Clarity and Efficiency to Early Drug Screening: How Chemical Protein Stability Assays (CPSA) Help Drive Decisions at the Hit/Lead Discovery Stage
We use cookies for various purposes including to make your experience of our website better. Please confirm below that you consent to our use of non-essential cookies in accordance with our cookies policy. Click here to access our cookies policy and find out more about our cookie use and how to disable cookies.